Gezielt nachschlagen
Suche
Suche startet nach einer kurzen Eingabepause.
20 angezeigte Treffer · Seite 2, keine Gesamtzahl für „TRALI“
Suchtreffer
Begriffe & Kennungen
Biopoin · 4.8 · Description of selected adverse reactions In patients with chronic renal failure, neutralising anti-erythropoi
Eintrag öffnenBreit neutralisierende Antikörper
Eintrag öffnenBrilique · 4.5 · Due to reports of cutaneous bleeding abnormalities with SSRIs (e.g. paroxetine, sertraline and citalopram), ca
Eintrag öffnenBrilique · 4.5 · Due to reports of cutaneous bleeding abnormalities with SSRIs (e.g. paroxetine, sertraline and citalopram), ca
Eintrag öffnenBrilique · 4.5 · Due to reports of cutaneous bleeding abnormalities with SSRIs (e.g. paroxetine, sertraline and citalopram), ca
Eintrag öffnenCACH-Syndrom
Eintrag öffnenChorda zentralis-Syndrom
Eintrag öffnenDarunavir Viatris (previously Darunavir Mylan) · 4.5 · Sertraline sertraline AUC ↓ 49% 50 mg once daily sertraline Cmin ↓ 49% sertraline Cmax ↓ 44% # darunavir AUC ↔
Eintrag öffnenEEG-Monitore
Eintrag öffnenEfavirenz/Emtricitabine/Tenofovir disoproxil Krka · 4.5 · 21 Cmax: ↓ 29% (↓ 15 to ↓ 40) disoproxil, sertraline dose Cmin: ↓ 46% (↓ 31 to ↓ 58) increases should be guide
Eintrag öffnenElaprase · 4.8 · 6 also tested positive for neutralizing antibodies on at least 3 consecutive study visits. Antibody-negative p
Eintrag öffnenElocta · 4.8 · Development of neutralising antibodies (inhibitors) may occur in patients with haemophilia A treated with fact
Eintrag öffnenElzonris · 4.8 · • 92% (155/169) of ADA-positive patients evaluable for the presence of neutralising antibodies post-treatment
Eintrag öffnenEmpliciti · 4.8 · 11 antibodies resolved by 2 to 3 months in 18 (95%) of these 19 patients. Neutralizing antibodies were detecte
Eintrag öffnenEnrylaze · 4.8 · A total of 23 (20%) patients who had ADAs experienced hypersensitivity reactions of which 6 (5%) had neutralis
Eintrag öffnenEnspryng · 4.5 · Given the prolonged terminal half-life of satralizumab, the effect of satralizumab may persist for several wee
Eintrag öffnenEnspryng · 4.5 · Therefore caution should be exercised when starting or discontinuing satralizumab treatment in patients also r
Eintrag öffnenEnspryng · 4.8 · 9.6% of patients receiving satralizumab had neutrophils below 1 x 109/L, compared with 5.4% receiving placebo
Eintrag öffnenEnspryng · 4.8 · Elevations in ALT or AST >3 x ULN occurred in 2.9% and 1.9% of patients treated with satralizumab (monotherapy
Eintrag öffnenEnspryng · 4.8 · IRRs reported in patients treated with satralizumab were predominantly mild to moderate, and most occurred wit
Eintrag öffnen